Market Trends of Personalized Nutrition Industry
Disease-based Segment Expected to Hold a Significant Share Over the Forecast Period
Disease-based personalized nutrition customizes dietary recommendations to manage or prevent specific health conditions. This approach considers an individual's health profile, including disease presence, severity, and nutrient response. For example, for someone with diabetes, personalized nutrition might focus on managing blood sugar levels through controlled carbohydrate intake. For instance, a study published in the Journal of Diabetes and Metabolic Disease in June 2023 discussed the roles of personalized nutrition (PN) in obesity and diabetes management. It concluded that PN, compared to conventional diets, can better improve metabolic status in obese and diabetic patients, considering genetic differences.
Additionally, in May 2024, Zoe launched a randomized controlled trial that compared an individual’s personalized dietary program (PDP) with postprandial glucose responses, microbiome data, and health history to produce personalized dietary supplements versus general dietary advice. The PDP group showed significant reductions in triglycerides and improvements in secondary outcomes like body weight, waist circumference, HbA1c, and diet quality. Thus, personalized nutrition helps in the management of metabolic diseases, and traditional nutrition is anticipated to bolster market growth.
The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and obesity has significantly impacted the demand for personalized nutrition. For instance, as per the Diabetes in Canada Report published in 2023, 4.12 million individuals, accounting for 10% of the population, were diagnosed with type 1 and type 2 diabetes in 2023. This figure is projected to rise to 5.19 million, representing 12% of the population, by 2033. This indicates a 26% increase in diabetes diagnoses (both type 1 and type 2) from 2023 to 2033. Thus, diabetes management might involve monitoring carbohydrate intake and glycemic response, which necessitates more tailored dietary interventions, thereby boosting market growth.
Similarly, as per the Australian Institutes of Health and Welfare, an estimated 1.3 million Australians aged 18 and over (6.7% of the adult population) lived with one or more conditions related to heart, stroke, and vascular disease in 2022. This included 600,000 adults (3.0%) who reported having coronary heart disease (including angina and heart attack). Thus, cardiovascular health requires specific adjustments in fat and sodium intake, and as these conditions become more common, there is a growing need for personalized approaches that can address the complexities of each individual’s health situation, leading to a more effective and tailored dietary strategy, thereby boosting market growth.
Furthermore, market players are engaging in the launch of personalized nutrition for the treatment of several metabolic diseases like diabetes and cardiovascular diseases, which are anticipated to bolster market growth. For instance, in November 2023, Sigrid Therapeutics launched its Glucose Stabiliser in the United States. This over-the-counter dietary supplement aids in blood sugar control and helps reduce calorie intake from fats and carbohydrates. Thus, launches of such products are expected to increase their adoption, contributing to the segment’s growth.
Thus, the growth of personalized nutrition is being driven by the increasing prevalence of chronic diseases, which necessitates more tailored dietary interventions; advancements in nutritional science and technology, which provide the tools for precise and individualized nutrition plans; and increased consumer awareness and demand for personalized health solutions. These factors collectively support the expansion of personalized nutrition as a viable and effective approach for managing health and improving dietary outcomes.
North America Expected to Hold a Significant Market Share Over the Forecast Period
North America currently holds the largest share of the global personalized nutrition market, with the United States emerging as a pivotal player. Factors such as heightened health consciousness, sophisticated healthcare infrastructure, and substantial investments in personalized nutrition technologies fuel the region's prominence. In the United States, the widespread occurrence of chronic diseases, coupled with a strong focus on preventive healthcare, has accelerated the embrace of personalized nutrition solutions.
With rising public awareness about health, consumers are increasingly turning to personalized nutrition solutions. This evolving demand is propelling the personalized nutrition market as individuals pursue bespoke solutions that align with their health conditions and lifestyle choices. For instance, in January 2024, AHARA unveiled its latest initiative, "AHARA for Employers," a business-to-business (B2B) program. As a frontrunner in personal nutrition advocacy, AHARA aims to empower North American employers to enhance employee well-being and productivity, all while curbing their healthcare expenses.
Furthermore, the growth of personalized nutrition is being driven by the rising prevalence of chronic diseases, which necessitates more tailored dietary interventions, contributing to market growth. As per the American Heart Association 2024, by 2050, the prevalence of various cardiovascular diseases (CVD) in the United States is expected to rise significantly. Specifically, coronary disease prevalence will increase from 7.8% to 9.2%, heart failure from 2.7% to 3.8%, stroke from 3.9% to 6.4%, and atrial fibrillation from 1.7% to 2.4%. Overall, total cardiovascular disease prevalence is projected to rise from 11.3% to 15.0% over the same period. These trends suggest that clinical CVD will impact 45 million adults, while CVDs, including hypertension, will affect over 184 million adults, representing more than 61% of the population. Alarmingly, similar trends are anticipated in children as well.
The increasing research and development activities on personalized nutrition are anticipated to bolster the demand in the market. For instance, in May 2023, the Illinois Institute of Technology stood out as one of the 14 selected institutions for the National Institute of Health’s groundbreaking initiative aimed at advancing nutrition research. The initiative, dubbed Nutrition for Precision Health (NPH) and driven by the All of Us Research Program, seeks to engage 10,000 participants from varied backgrounds across the United States. Such research guides the physician in tailoring the nutrition for the patient and is anticipated to bolster market growth.
Additionally, the launch of personalized nutrition supplements in the market is expected to increase its adoption, driving market growth. For instance, in July 2022, Healthycell and Panaceutics teamed up to introduce personalized and adaptive human nutritional supplements for heart, gut, and bone health. They utilize a patent-pending, pill-free gel formulation technology, allowing for infinitely variable customization.
Recent advances in nutritional science and technology have revolutionized the field of personalized nutrition. Advancements allow for the development of highly personalized nutrition plans that are based on precise biological data, leading to more effective and targeted dietary recommendations. For instance, in June 2023, the American Diabetes Association (ADA) and Abbott teamed up to explore how diabetes technologies, such as continuous glucose monitoring (CGM) systems, can empower individuals with diabetes to make informed choices regarding their diet and activities.
Consequently, factors like the rising awareness of personalized nutrition, the increasing burden of chronic diseases, and advancements in research, development, and technology are expected to drive market growth.
